Minimally invasive (robotic or laparoscopic) surgery has been widely adopted for the treatment of cancer despite few randomized, controlled trials assessing outcomes.
1 In the Laparoscopic Approach to Cervical Cancer (LACC) Trial, the results of which were reported by Ramirez et al.
2 in the
Journal in November 2018, patients with early-stage cervical cancer were randomly assigned to undergo minimally invasive surgery or open abdominal radical hysterectomy. Minimally invasive surgery was associated with worse disease-free and overall survival than open surgery. A population-based study
3 and a meta-analysis
4 showed similar associations. Accordingly, guidelines now favor open surgery (Table S1 in the Supplementary Appendix, available with the full text of this letter at NEJM.org). Nevertheless, the extent to which practice has changed is unknown.